Funder
Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Reference72 articles.
1. Breaking the therapeutic ceiling in drug development in ulcerative colitis;Alsoud;Lancet Gastroenterol,2021
2. The global burden of IBD: from 2015 to 2025;Kaplan;Nat. Rev. Gastro. Hepat.,2015
3. REV-ERBα integrates colon clock with experimental colitis through regulation of NF-κB/NLRP3 axis;Wang;Nat. Commun.,2018
4. Ulcerative colitis;Le Berre;The Lancet,2023
5. Reactive Oxygen Species (ROS)-based nanomedicine;Yang;Chem. Rev.,2019